Catalyst Wire Dossier Catalyst Wire Dossier

Ganfort

bimatoprost; timolol · AbbVie Deutschland GmbH & Co. KG
Drug timelines are a Plus or Pro feature.

13 regulatory and trial events tracked for Ganfort, covering 2011-05-30 to 2024-11-18. Get the full timeline:

Most recent: EMA Authorised: Ganfort (bimatoprost;timolol) — AbbVie Deutschland GmbH & Co. KG

See pricing